MedTrace Logo

BiPAP for Cardiomyopathy With Central Sleep Apnea

NCT00282789 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2006-01-30

No results posted yet for this study

Summary

We investigated whether treatment of central sleep apnea-hypopnea with bilevel positive airway pressure (BiPAP) in patients with idiopathic dilated cardiomyopathy (IDCM) would improve LV function.

Conditions

  • Dilated Cardiomyopathy

Interventions

DEVICE

bilevel positive airway pressure

DEVICE

bilevel positive airway pressure (Device)

Sponsors & Collaborators

  • Nagoya University

    lead OTHER

Principal Investigators

  • Mitsuhiro Yokota, MD,PhD · Department of Cardiovascular Genome Science, Nagoya University School of Medicine, Nagoya, Aichi, Japan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-06-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00282789 on ClinicalTrials.gov